ROME THERAPEUTICS

Live / Registered — Registered (as of 17 Feb 2026)

What this means for you

Registered since 17 Feb 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 17 Feb 2032: the §8 declaration of use).

Record

Serial number
97187984
Registration number
8145678
Mark type
Stylized text
Filed
23 Dec 2021
Published for opposition
10 Dec 2024
Registered
17 Feb 2026
Next maintenance filing
§8 declaration of use, due by 17 Feb 2032 (grace period to 17 Aug 2032)
Attorney of record
GLENN A GUNDERSEN

Goods and services

  • Class 042 — Scientific and technological services: Pharmaceutical research and development in the field of cancer and autoimmune disease; pharmaceutical drug development and discovery services in the field of cancer and autoimmune disease; scientific research in the field of pharmaceuticals; providing scientific research information in the field of pharmaceuticals; none of the foregoing relating to gastrointestinal issues

Owner

Board proceedings on this mark

The owner also pleads this mark in 1 other Board proceeding.

Prosecution history

  • 17 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
  • 17 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
  • 26 Jan 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
  • 26 Jan 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
  • 22 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 21 Jan 2026 — STATEMENT OF USE PROCESSING COMPLETE
  • 30 Jul 2025 — USE AMENDMENT FILED
  • 21 Jan 2026 — SOU EXTENSION 2 GRANTED
  • 30 Jul 2025 — SOU EXTENSION 2 FILED
  • 31 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
  • 30 Jul 2025 — TEAS STATEMENT OF USE RECEIVED
  • 30 Jul 2025 — SOU EXTENSION 1 GRANTED
  • 30 Jul 2025 — SOU EXTENSION 1 FILED
  • 30 Jul 2025 — SOU TEAS EXTENSION RECEIVED
  • 04 Feb 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT

View this trademark record on Rightsy